- Home
- FSEA vs INMB Comparison
FSEA vs INMB Comparison
Compare FSEA & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FSEA | INMB |
|---|---|---|
| Founded | 1890 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 64.7M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FSEA | INMB |
|---|---|---|
| Price | $17.17 | $2.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 3.0K | ★ 307.9K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $11.08 | $1.09 |
| 52 Week High | $17.21 | $2.60 |
Technical Indicators
Market Signals| Indicator | FSEA | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 70.87 | 55.16 |
| Support Level | $16.84 | $2.21 |
| Resistance Level | $17.21 | $2.50 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 93.75 | 32.93 |
Price Performance
Historical ComparisonAbout FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is the savings and loan holding company. The banks business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one- to four-family residential real estate loans, commercial real estate and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. It operates in single segment of Banking Services.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.